鮸鱼长链非编码RNA MRL调控MyD88介导的抗细菌信号通路的分子机制
批准号:
42106125
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
初青
依托单位:
学科分类:
生物海洋学与海洋生物资源
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
初青
中文摘要
海水养殖鱼类的细菌性疾病给养殖产业造成了严重损失,目前主流的抗生素治疗方式会导致耐药菌株的出现并增加食物安全风险,基于基因免疫疗法的生物防控策略可以提高机体自身免疫力进而增强抗病力,而前提是首先需要发现能够增加鱼类机体免疫力的免疫增强子。申请人前期筛选出一个在哈维氏弧菌感染后的鮸鱼中高表达的长链非编码RNA(lncRNA)并命名为MRL,过表达和敲降后能分别促进和抑制炎症细胞因子的表达,通过RIP技术鉴定出MRL可以与miRNA调控元件AGO2结合,说明MRL可能作为ceRNA参与了miRNA的调控过程,进一步发现MRL可以正调控TLR抗细菌通路中接头分子MyD88的表达,推测lncRNA MRL与miRNA竞争性互作共同调控MyD88介导的抗细菌通路。本项目旨在阐明MRL调控鱼类抗细菌通路的分子机制,揭示鮸鱼病害的防控及鱼类免疫调控机理,为鱼类的疾病防控及健康养殖奠定理论基础。
英文摘要
Bacterial diseases of mariculture fish have caused serious losses to the aquaculture industry. The current mainstream antibiotic treatment methods have led to the emergence of drug-resistant strains and increased food safety risks. Biological prevention and control strategies based on gene immunotherapy can improve the body’s own immunity. To enhance disease resistance, the prerequisite is to find immune enhancers that can increase the immunity of fish. The applicant previously screened a long non-coding RNA (lncRNA), named MRL, which was highly expressed in Miichthys miiuy infected with Vibrio harveyi. Overexpression or knockdown of lncRNA MRL can promote or inhibit the expression of inflammatory cytokines, respectively. The RIP experiment showed that MRL can bind to the miRNA regulatory element AGO2, indicating that MRL may serves as a ceRNA for miRNA. Furthermore, it was found that MRL can positively regulate the expression of MyD88 in the TLR antibacterial pathway. It is speculated that lncRNA MRL can act as a competing endogenous RNA of miRNA to regulate the antibacterial pathway mediated by MyD88. This project aims to clarify the molecular mechanism of lncRNA MRL regulating fish anti-bacterial pathways, reveal the prevention of fish diseases and the molecular mechanism of fish immunity, and lay a theoretical foundation for fish disease prevention and control and healthy breeding.
在鱼类养殖中,细菌性疾病是危害最为严重的一类疾病,目前主流的抗生素治疗方式会导致耐药菌株的出现,基于基因免疫疗法的生物防控策略可以提高机体自身免疫力进而增强抗病力,而前提是首先需要发现能够增加鱼类机体免疫力的免疫增强子。申请人前期筛选出一个在哈维氏弧菌感染后的鮸鱼中高表达的长链非编码RNA LTCONS4500(又名lncRNA MRL),过表达和沉默LTCONS4500后能分别促进和抑制炎症细胞因子的表达,但该lncRNA调控鱼类抗细菌通路的具体分子机制尚不明确。在此基础上,本研究在鮸鱼肝脏细胞中过表达或沉默LTCONS4500,进行LPS刺激后,通过实时荧光定量PCR(qPCR)和荧光素酶检测技术对MyD88介导的信号通路分子、NF-κB等转录因子、及炎症细胞因子进行定量检测,明确了LTCONS4500能正调控MyD88介导的免疫信号通路及炎症细胞因子的表达;通过生物信息软件、RNA结合蛋白免疫沉淀(RIP)及RNA pulldown验证出可同时与LTCONS4500和MyD88互作的miRNA为miR-3570-5p;然后,通过蛋白质免疫印迹(Western blot)及qPCR等技术,明确MyD88是miR-3570-5p的靶基因;将合成的miR-3570-5p的模拟体及抑制体分别转染至鮸鱼细胞系中,LPS刺激细胞后,利用qPCR、Western blot等技术,阐明miR-3570-5p能够负调控MyD88、MyD88下游基因及炎症细胞因子;最后,以组合方式过表达LTCONS4500、miR-3570-5p或MyD88,通过qPCR、Western blot、荧光素酶检测技术阐明了LTCONS4500可作为miR-3570-5p的海绵体促进MyD88的表达并进一步促进NF-κB等转录因子及炎症细胞因子的表达,证实了LTCONS4500可作为增加鱼类机体免疫力的免疫增强子。预期通过本项目的实施,将有利于加深对非编码RNA在低等脊椎动物生命过程中作用的认识,丰富鱼类先天性免疫信号通路的调控网络,揭示鮸鱼病害的防控及鱼类免疫调控机理,为开展鱼类的靶向基因免疫疗法及健康养殖奠定理论基础。
国内基金
海外基金